July 17, 2012
Washington, DC
Food and Drug Law Institute
Finnegan partner Rich Racine will participate in the panel discussion “The Role of IP During Drug Discovery and Pre-Clinical Development” at the Food and Drug Law Institute’s IP drug discovery lifecycle forum. The program will take place at the offices of Venable LLP in Washington, DC. For more information, or to register, please see FDLI’s website.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.